| TC | Stat | Stk | Ins | Fil | +d | +w | +m | +q | +h | +y | avg | 
|---|
| Filing Date | T Date | Ticker | Issuer | Inc | Sector | Ind | Industry | Owner | oSt | Rel | Title | T | TVal | Price | L | Qty | oc | Own | H | r2y | r1y | r6m | r3m | r6w | r3w | r7d | r3d | f1d | f1w | f1m | f3m | f6m | f1y | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1/14/25 18:08 | 1/10/25 | FTRE | Fortrea Holdings Inc. | Health | Health | Medical Laboratories | Pike Thomas | NC | DO | CEO | M.d | 0 | 0.00 | 0 | 40 | 34 | 160 | D | |||||||||||||||
| 1/14/25 18:08 | 1/13/25 | FTRE | Fortrea Holdings Inc. | Health | Health | Medical Laboratories | Pike Thomas | NC | DO | CEO | S.d | -203 | 18.04 | 0 | -11 | -7 | 160 | D | |||||||||||||||
| 8/20/24 17:34 | 8/19/24 | FTRE | Fortrea Holdings Inc. | Health | Health | Medical Laboratories | Pike Thomas | NC | DO | CEO | M.d | 0 | 0.00 | 0 | 126 | 999% | 131 | D | |||||||||||||||
| 5/30/24 16:34 | 5/29/24 | FTRE | Fortrea Holdings Inc. | Health | Health | Medical Laboratories | Pike Thomas | NC | DO | CEO | P | 248 | 24.81 | 0 | 10 | 21 | 58 | D | |||||||||||||||
| 1/11/24 18:12 | 1/9/24 | FTRE | Fortrea Holdings Inc. | Health | Health | Medical Laboratories | Pike Thomas | NC | O | CEO | M.d | 0 | 0.00 | 0 | 40 | 529 | 48 | D | |||||||||||||||
| 8/23/23 21:09 | 8/23/23 | FTRE | Fortrea Holdings Inc. | Health | Health | Medical Laboratories | Pike Thomas | NC | O | CEO | P | 505 | 25.23 | 0 | 20 | New | 20 | D | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |